Infectious Disease Life Cycle and Transmission Modes

Learning Objectives and Key Terminology

• Goal of the Lecture: To establish a comprehensive understanding of the infectious disease life cycle, routes of pathological entry into the human body, modes of infection/transmission, and common infections caused by pathogens along with their antibiotic targets.

• Aetiology: The study of the cause or origin of a disease.

• Pathogenesis: The manner of development of a disease; the biological mechanism that leads to a diseased state.

• Microbemia: The presence of microorganisms (such as bacteria or fungi) in the circulating blood.

Host Defence Mechanisms

The human body utilizes two primary forms of defense against infection:

• Non-specific Defences: This represents the first and second lines of defense that do not target a specific pathogen.

  • Physical Barriers: Skin and mucous membranes.

  • Internal Defenses: White blood cells, inflammation processes, and various defensive proteins.

• Specific Defences (Adaptive Immunity):

  • Cellular Component: Includes specialized White blood cells, specifically B-lymphocytes and T-lymphocytes.

  • Immune Responses: Comprises both humoral (antibody-mediated) and cell-mediated immunity.

  • Memory and Recognition: Antibodies facilitate the recognition of previously encountered infections, a principle utilized in vaccine design and effectiveness.

Bacterial Pathogenesis and Public Health

• Multi-factorial Process: The development of bacterial disease is dependent on:

  • The immune status of the host.

  • Specific characteristics of the bacterial species or strain.

  • The number of organisms involved in the initial exposure (infectious dose).

• Current State of Infectious Diseases:

  • Only a limited number of bacterial species are responsible for the vast majority of human infectious diseases.

  • Successes: Many infections have been eradicated or significantly reduced through the deployment of vaccines, antibiotics, and effective public health measures.

  • Persistent Challenges: The medical field continues to struggle with antibiotic resistance, the threat of bioterrorism, and the emergence of new, novel infections.

The Epidemiologic Triangle

The occurrence of disease is determined by the interaction of three main factors:

• The Host: Factors include Age, Sex, Genotype, Behaviour (lifestyle), Nutritional status, and general Health status.

• The Agent: Factors include Infectivity, Pathogenicity, Virulence, Immunogenicity, Antigenic stability, and Survival capabilities.

• The Environment: External factors such as Weather, Housing conditions, Geography, Occupational settings, Air quality, and Food safety.

The Five Steps of a Successful Infection Life Cycle

To establish a successful infection, a pathogen typically follows a five-step sequence:

1. Transmission: Moving from a source to the host.

2. Adhesion: Attaching to host tissues.

3. Penetration: Entering the host's system or cells.

4. Spread: Disseminating through the body.

5. Survival in Host: Evading the host's immune response to persist and potentially multiply.

Mechanisms of Tissue Injury: Endotoxins vs. Exotoxins

Bacteria cause tissue injury primarily through exotoxins, endotoxins, and siderophores.

Endotoxins

• Nature: These are toxic lipopolysaccharide (LPS) components found in the outer membrane of Gram-negative bacteria.

• Release: They are secured to the outer membrane and are only released after the lysis (death and breakdown) of the bacteria.

• Biological Effects: Symptoms include pyrogenicity (fever), leukopenia (low white blood cell count), and negative impacts on blood pressure. These events can culminate in sepsis and lethal shock.

• Examples: $Salmonella$ spp. and $E. coli$.

Exotoxins

• Nature: Proteins released from viable (living) bacteria; they are considered the most toxic substances known.

• Source: Produced by both Gram-positive and Gram-negative cells, though more common in Gram-positive bacteria as part of their growth and metabolism.

• Functional Categories:

  • Neurotoxins: Target the nervous system (e.g., botulinum toxin from $Clostridium\,botulinum$).

  • Cytotoxins: Kill host cells directly (e.g., diphtheria toxin from $Corynebacterium\,diphtheriae$).

  • Enterotoxins: Target the gastrointestinal tract (e.g., shiga-like enterotoxin from $E. coli$).

Methods of Transmission

• Contact Transmission:

  • Direct/Droplet: Spread by airborne droplets traveling short distances ( < 3\,\text{feet}).

  • Path: Transmission directly from the source to a susceptible host.

  • Example: $Pseudomonas$ organisms.

• Common Vehicle Transmission:

  • Medium: Transmission via a common inanimate vehicle (e.g., contaminated food or water).

  • Impact: Usually results in multiple cases from the same exposure source.

  • Example: Salmonellosis.

• Airborne Transmission:

  • Medium: Spread via droplet nuclei or dust particles traveling longer distances ( > 3\,\text{feet}).

  • Example: Tuberculosis.

• Vector Transmission:

  • Medium: Arthropods (insects/arachnids) serve as vectors; the pathogen may be internalized within the vector or carried externally.

  • Example: Malaria.

Routes of Pathological Entry and Virulence Factors

General Entry Principles

• Entry site specificity is critical for individual pathogens.

• Following establishment, pathogens may remain at the entry site or migrate and multiply in different anatomical areas.

Bacterial Virulence Factors

• Adherence/Colonization Factors: Attachment mechanisms like pili (e.g., in $E. coli$ and $Salmonella$ spp.).

• Invasion Factors: Mechanisms allowing the bacterium to enter eukaryotic cells (e.g., $Rickettsia$ and $Chlamydia$ spp.).

• Capsules and Surface Components: Protective capsules allow bacteria to resist phagocytosis and intracellular killing (e.g., $Salmonella\,typhi$).

Specific Portals of Entry

• Skin:

  • Entry usually occurs through breaks in the skin (e.g., insect bites).

  • Infections can be primary (originating in the skin) or secondary (skin symptoms resulting from systemic toxins, like in measles).

  • Common signs include erythema (redness) and oedema (swelling).

• Respiratory Tract:

  • Upper Respiratory Tract Infections (URTIs): Organisms are inhaled via droplets and invade the mucosa. Examples include the Common Cold, caused by Rhinovirus ($25\%$), Coronaviruses ($10\%$), and undetermined causes ($30-40\%$). Symptomatic onset occurs after a $48-72\,\text{h}$ incubation period.

  • Lower Respiratory Tract Infections (LRTIs): Organisms enter distal airways via inhalation, aspiration, or haematogenous seeding (via the blood). Example: Pneumonia.

• Urogenital Tract:

  • Infections often cause painful, frequent urination, fever, and back pain.

  • Causes: Sexually transmitted infections (STIs) or resident flora (e.g., $E. coli$ causes $70\%$ of urinary tract infections).

  • Organisms can ascend through the urethra to the bladder and renal pelvis.

• Conjunctiva:

  • Ideally free of microbes due to continuous secretion (tears).

  • Damage to the conjunctiva or reduced tear flow allows opportunistic infections (Conjunctivitis).

  • Examples: $Chlamydia\,trachomatis$ and $Staphylococcus\,aureus$.

Detailed Example: Chlamydia

• Organism: $Chlamydia\,trachomatis$ causes ocular and genital infections.

• Nature: They are obligate intracellular bacteria, lacking several metabolic and biosynthetic pathways.

• Life Cycle Stages:

  1. Elementary Bodies: Infectious particles.

  2. Reticulate Bodies: Intracytoplasmic, reproductive forms.

• Complication: Genital tract infections serve as a reservoir for elementary bodies that can eventually infect the eyes.